WA
AGTC

Wilshire Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Wilshire Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,378
Closed -$42K – 29
2018
Q2 		$42K Buy
+11,378
New +$52.6K 0.04% 26

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Wilshire Advisors's AGTC Position: Q3 2018 in Review

Wilshire Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2018, closing a stake of 11,378 shares — an estimated $42K sold.

Wilshire Advisors first reported a position in AGTC in Q2 2018 and held it in 1 quarter. The position peaked at $42K in Q2 2018. 61 funds tracked by Wall St. Rank hold AGTC as of Q3 2018.

  • Wilshire Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q3 2018 after selling out during the quarter.
  • Wilshire Advisors sold 11,378 Applied Genetic Technologies Corporation shares in Q3 2018, an estimated $42K.
  • Wilshire Advisors first reported a position in Applied Genetic Technologies Corporation in Q2 2018 and held it in 1 quarter.
  • Wilshire Advisors's Applied Genetic Technologies Corporation position peaked at $42K in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2018.

Based on Wilshire Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.